Published in J Infect Dis on June 01, 1993
Cytokine modulation alters pulmonary clearance of Rhodococcus equi and development of granulomatous pneumonia. Infect Immun (1995) 1.14
Identification of pulmonary T-lymphocyte and serum antibody isotype responses associated with protection against Rhodococcus equi. Clin Diagn Lab Immunol (2002) 1.04
Macrophage-related diseases of the gut: a pathologist's perspective. Virchows Arch (2012) 0.96
Tumour necrosis factor and interferon-gamma are required in host resistance against virulent Rhodococcus equi infection in mice: cytokine production depends on the virulence levels of R. equi. Immunology (1999) 0.89
Cytokine induction in murine macrophages infected with virulent and avirulent Rhodococcus equi. Infect Immun (1998) 0.89
Failure of a VapA/CpG oligodeoxynucleotide vaccine to protect foals against experimental Rhocococcus equi pneumonia despite induction of VapA-specific antibody and interferon-γ response. Can J Vet Res (2013) 0.75
Characterization of a novel extended-spectrum beta-lactamase from Pseudomonas aeruginosa. Antimicrob Agents Chemother (1993) 3.44
Characterization of Class 1 integrons from Pseudomonas aeruginosa that contain the bla(VIM-2) carbapenem-hydrolyzing beta-lactamase gene and of two novel aminoglycoside resistance gene cassettes. Antimicrob Agents Chemother (2001) 2.73
An SHV-derived extended-spectrum beta-lactamase in Pseudomonas aeruginosa. Antimicrob Agents Chemother (1999) 2.15
Identification of clinical coagulase-negative staphylococci, isolated in microbiology laboratories, by matrix-assisted laser desorption/ionization-time of flight mass spectrometry and two automated systems. Clin Microbiol Infect (2009) 1.88
Expression of IL-17 in human memory CD45RO+ T lymphocytes and its regulation by protein kinase A pathway. Cytokine (1999) 1.45
Production and characterization of monoclonal antibodies against rat brush border antigens of the proximal convoluted tubule. Immunology (1984) 1.42
Selective up-regulation of chemokine IL-8 expression in cystic fibrosis bronchial gland cells in vivo and in vitro. Am J Pathol (1998) 1.31
In-vitro antimicrobial susceptibility of Rhodococcus equi. J Antimicrob Chemother (1992) 1.31
Production of interleukin 1 and tumour necrosis factor activities in bronchoalveolar washings following infection of mice by influenza virus. J Gen Virol (1990) 1.28
Role of H-2 and non-H-2 genes in control of bacterial clearance from the spleen in Salmonella typhimurium-infected mice. Infect Immun (1988) 1.28
The first clinical isolate of Legionella parisiensis, from a liver transplant patient with pneumonia. J Clin Microbiol (1997) 1.22
Pyrimethamine-sulfadoxine treatment of congenital toxoplasmosis: follow-up of 78 cases between 1980 and 1997. Reims Toxoplasmosis Group. Scand J Infect Dis (1998) 1.19
Extended-spectrum β-lactamase TEM-4 in Pseudomonas aeruginosa. Clin Microbiol Infect (1999) 1.17
Role of T-lymphocyte subsets in Rhodococcus equi infection. Infect Immun (1992) 1.16
Implication of interleukin-4 in wound healing. Lab Invest (2000) 1.15
Host response to infection with a temperature-sensitive mutant of Salmonella typhimurium in a susceptible and a resistant strain of mice. Infect Immun (1985) 1.13
Regulation of IL-17, IFN-gamma and IL-10 in human CD8(+) T cells by cyclic AMP-dependent signal transduction pathway. Cytokine (1998) 1.12
Therapy of Rhodococcus equi disseminated infections in nude mice. Antimicrob Agents Chemother (1992) 1.12
Genetic environment of acquired bla(ACC-1) beta-lactamase gene in Enterobacteriaceae isolates. Antimicrob Agents Chemother (2006) 1.08
Genetic context of plasmid-carried blaCMY-2-like genes in Enterobacteriaceae. Antimicrob Agents Chemother (2009) 1.05
Impairment of lymphocyte proliferative responses and interleukin-2 production in susceptible (C57BL/6) mice infected with Salmonella typhimurium. Immunology (1986) 1.05
Involvement of tumor necrosis factor alpha in intracellular multiplication of Legionella pneumophila in human monocytes. Infect Immun (1993) 1.03
Differential regulation of TNF alpha, IL-1 beta, IL-6, IL-8, TNF beta, and IL-10 by pentoxifylline. Int J Immunopharmacol (1996) 1.02
Differential regulation of IFN-gamma, IL-10 and inducible nitric oxide synthase in human T cells by cyclic AMP-dependent signal transduction pathway. Immunology (1997) 1.02
Alveolar type II epithelial cells produce interleukin-6 in vitro and in vivo. Regulation by alveolar macrophage secretory products. J Clin Invest (1994) 1.02
Plasma levels of tumor necrosis factor-alpha (TNF-alpha) are essentially dependent on visceral fat amount in type 2 diabetic patients. Diabetes Metab (2000) 1.00
Induction of interleukin 1 secretion by adjuvant-active peptidoglycans. Infect Immun (1983) 0.99
[Enterobacter cloacae and E. aerogenes septicemia: emergence of resistant variants (derepressed cephalosporinase) during treatment with third-generation cephalosporins]. Presse Med (1985) 0.98
Activation of the cellular mitogen-activated protein kinase pathways ERK, P38 and JNK during Toxoplasma gondii invasion. Parasite (2003) 0.93
Dysregulation of IL-2 and IL-8 production in circulating T lymphocytes from young cystic fibrosis patients. Clin Exp Immunol (2004) 0.93
Murine monoclonal antibodies to Klebsiella pneumoniae protect against lethal endotoxemia and experimental infection with capsulated K. pneumoniae. Infect Immun (1990) 0.93
Correlation between antibiotic resistance, phage-like particle presence, and virulence in Rhodococcus equi human isolates. J Clin Microbiol (1994) 0.92
Pulmonary abscess due to a rifampin and fluoroquinolone resistant Rhodococcus equi strain in a HIV infected patient. Eur J Clin Microbiol Infect Dis (1992) 0.91
Protective effects of murine monoclonal antibodies in experimental septicemia: E. coli antibodies protect against different serotypes of E. coli. J Infect Dis (1989) 0.91
Comparative study of biological activities and mitogenic effect of extracts from Haemophilus influenzae type a. Med Microbiol Immunol (1980) 0.91
Influence of different regions of the H-2 complex on the rate of clearance of Salmonella typhimurium. Infect Immun (1990) 0.91
Differential spontaneous expression of mRNA for IL-4, IL-10, IL-13, IL-2 and interferon-gamma (IFN-gamma) in peripheral blood mononuclear cells (PBMC) from atopic patients. Clin Exp Immunol (1996) 0.90
Molecular typing of Legionella pneumophila serogroup 1 isolates from patients and the nosocomial environment by arbitrarily primed PCR and pulsed-field gel electrophoresis. J Med Microbiol (1999) 0.90
Genetic control of Salmonella typhimurium-induced depression of delayed-type hypersensitivity to sheep erythrocytes in mice. Infect Immun (1988) 0.88
Effect of hydroxyapatite sintering temperature on intracellular ionic concentrations of monocytes: a TEM-cryo-X-ray microanalysis study. J Biomed Mater Res (2001) 0.88
Interferon-gamma signal transduction during parasite infection: modulation of MAP kinases in the infection of human monocyte cells (THP1) by Toxoplasma gondii. Parasite Immunol (1998) 0.87
Inhibition of human TNF alpha and LT in cell-free extracts and in cell culture by antisense oligonucleotides. Biochim Biophys Acta (1996) 0.87
Role of interferon-gamma against invasion by Toxoplasma gondii in a human monocytic cell line (THP1): involvement of the parasite's secretory phospholipase A2. Cell Immunol (1996) 0.85
Human alpha 1-acid glycoprotein-exposed macrophages release interleukin 1 inhibitory activity. Biochem Biophys Res Commun (1987) 0.84
Suppression of primary antibody response in genetically susceptible mice infected with Salmonella typhimurium: restoration by catalase. Res Immunol (1989) 0.84
Characteristics of a lipid preparation (lipid A) from Haemophilus influenzae type a lipopolysaccharide. Infect Immun (1981) 0.84
Regulatory effects of pentoxifylline on T-helper cell-derived cytokine production in human blood cells. J Cardiovasc Pharmacol (1995) 0.84
[Detection of extended broad-spectrum beta-lactamases with the ATB MIC system]. Pathol Biol (Paris) (1991) 0.83
Inhibition of production of tumor necrosis factor by monoclonal antibodies to lipopolysaccharides. J Infect Dis (1992) 0.83
Study of adjuvant and mitogenic activities of bacterial peptidoglycans with different structures. Ann Immunol (Paris) (1983) 0.83
Sodium periodate-induced suppressor T cells of the human in vitro antibody response. Cell Immunol (1980) 0.82
Interaction of virulent and non-virulent Rhodococcus equi human isolates with phagocytes, fibroblast- and epithelial-derived cells. FEMS Immunol Med Microbiol (1994) 0.82
Regulation of tumor necrosis factor alpha and its specific receptors during Toxoplasma gondii infection in human monocytic cells. Parasitol Res (2002) 0.80
Antisense oligonucleotides to interleukin-4 regulate IgE and IgG2a production by spleen cells from Nippostrongylus brasiliensis-infected rats. Eur J Immunol (1993) 0.80
Tumour necrosis factor, IL-1 and IL-6 in bronchoalveolar washings and their in vitro production during Nippostrongylus brasiliensis infection. Clin Exp Immunol (1992) 0.80
Inhibition by sodium periodate of the in vitro antibody response of mouse spleen cells and its reversal by borohydride or aldehyde blocking reagents. Cell Immunol (1981) 0.79
Direct evidence for sialic acid oxidation in periodate-induced lymphocyte proliferation. Biochem Biophys Res Commun (1978) 0.79
Does human toxoplasmosis involve an imbalance in T1/T2 cytokines? Med Hypotheses (1997) 0.79
Study of pentoxifylline induced modulation of TNF alpha and interleukin-6 secretion in healthy and septic patients by the use of an ex-vivo model on whole blood. Nouv Rev Fr Hematol (1992) 0.78
Elastokine-mediated up-regulation of MT1-MMP is triggered by nitric oxide in endothelial cells. Int J Biochem Cell Biol (2007) 0.78
Involvement of tumor necrosis factor-alpha during infection of human monocytic cells by Toxoplasma gondii. Parasitol Res (2000) 0.78
Cuprophane but not synthetic membrane induces increases in serum tumor necrosis factor-alpha levels during hemodialysis. Am J Kidney Dis (1994) 0.78
HIV-1 gp160 decreases the K+ voltage-gated current from Jurkat E6.1 T cells by up-phosphorylation. FEBS Lett (1999) 0.78
[Effect of periodate oxidation of glycoconjugates of lymphocyte membranes on the immune response in vitro]. C R Acad Sci Hebd Seances Acad Sci D (1978) 0.78
Immunological activities of RU-41740, a glycoproteic extract from Klebsiella pneumoniae. II.--Activation of macrophage cytotoxicity against tumour cells and production of a cytotoxic factor. Ann Inst Pasteur Immunol (1988) 0.77
RU-41740 (K. pneumoniae glycoprotein) enhances resistance to experimental candidiasis and stimulates phagocytic functions. Ann Inst Pasteur Immunol (1987) 0.77
Release of a cytotoxic factor by macrophages stimulated with adjuvant-active peptidoglycans. J Natl Cancer Inst (1986) 0.77
[Aeromonas hydrophila septicemia: 3 cases, 1 with mediastinitis]. Ann Med Interne (Paris) (1984) 0.77
In vitro immunological activities of the polysaccharide fraction from Haemophilus influenzae type a endotoxin. Infect Immun (1982) 0.77
Induction of interleukin 1 secretion by murine macrophages and human monocytes after stimulation by RU 41740, a bacterial immunomodulator. Int J Immunopharmacol (1985) 0.77
[Respiratory burst of neutrophils and cytokine profile in the non-insulin-dependent diabetic]. J Mal Vasc (1995) 0.76
[Comparative in vitro antistaphylococcal effect of norfloxacin and pefloxacin on 312 hospital strains]. Pathol Biol (Paris) (1985) 0.76
[Broad spectrum beta-lactamases and the API ATB 244 system: the need for detection]. Pathol Biol (Paris) (1989) 0.76
Immunological activities of RU-41740, a glycoproteic extract from Klebsiella pneumoniae. I.--Activation of murine B cells and induction of interleukin-1 production by macrophages. Ann Immunol (Paris) (1984) 0.76
Behavior of aldehyde moieties involved in the activation of suppressor cells by sodium periodate. J Immunol (1987) 0.76
Induction of suppressor cells by sodium periodate: the opposite expression of periodate-induced lymphocyte activation in spleen cells of normal and nude mice. Immunology (1979) 0.75
Periodate-induced transformation of human peripheral blood lymphocytes and the resultant oxidation of membrane sialyl, galactosyl and fucosyl residues. Biochim Biophys Acta (1981) 0.75
Interleukin 1, a mediator of immunoadjuvant peptidoglycans. Comp Immunol Microbiol Infect Dis (1985) 0.75
Mediastinitis due to non-typhi Salmonella. Clin Infect Dis (1994) 0.75
[Rapid determination of the synergy of clavulanic acid and beta lactams by measuring the intracellular ATP by bioluminescence]. Ann Microbiol (Paris) (1983) 0.75
[In vitro sensitivity at 18 antibiotics of 192 strains of Pseudomonas aeruginosa isolated at Garches Hospital]. Pathol Biol (Paris) (1987) 0.75
[Activation of murine B lymphocytes by RU 41740, a glycoprotein extract from Klebsiella pneumoniae]. C R Acad Sci III (1984) 0.75
Diagnostic and therapeutic problems due to cat scratch disease. J Infect (1995) 0.75
[Legionnaires' disease in the Paris area: epidemiology and mortality. Apropos of a series of 81 culture-positive cases]. Presse Med (1996) 0.75
[In vitro and in vivo activity of a combination of clavulanic acid and amoxicillin against Klebsiella pneumoniae producing extended broad-spectrum betalactamase (CTX-1, SHV-3, SHV-4)]. Pathol Biol (Paris) (1989) 0.75
Immunological activities of RU-41740, a glycoprotein extract from Klebsiella pneumoniae. III. Role of LPS-like and LPS-non-related molecules. Res Immunol (1989) 0.75
[Current status of aminoglycoside resistance in hospital Enterobacteriaceae]. Pathol Biol (Paris) (1988) 0.75
Effect of cytokine-specific antisense oligonucleotides on the immunoglobulin production by rat spleen cells in vitro. Biochimie (1993) 0.75
Immunomodulation by cytokine antisense oligonucleotides. Eur Cytokine Netw (1995) 0.75
[Effect of a mitogenic concentration on membrane glycoconjugates of human lymphocytes]. C R Seances Acad Sci D (1980) 0.75
[Production of suppressor factor(s) in the in vitro antibody response by periodate oxidized spleen cells]. C R Seances Acad Sci III (1982) 0.75
[Periodate oxidation of lymphocyte membrane glycoconjugates]. C R Acad Sci Hebd Seances Acad Sci D (1977) 0.75
[Routine screening of antibiotic-resistant bacteria in acute rehabilitation units]. Pathol Biol (Paris) (2004) 0.75
[Modulation by quinolones of the in vitro proliferative response of splenic cells of the mouse and IL 1 production]. Pathol Biol (Paris) (1987) 0.75
[In vitro activity of 4 fluoroquinolones against Klebsiella pneumoniae. Distribution according to phenotype resistance to aminoglycosides or beta-lactams]. Pathol Biol (Paris) (1990) 0.75